SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-036598
Filing Date
2024-02-14
Accepted
2024-02-14 17:18:30
Documents
8

Document Format Files

Seq Description Document Type Size
1 424B5 d770368d424b5.htm 424B5 385633
2 GRAPHIC g770368g01k22.jpg GRAPHIC 85761
3 GRAPHIC g770368g01p01.jpg GRAPHIC 59263
4 GRAPHIC g770368g06a06.jpg GRAPHIC 198564
5 GRAPHIC g770368g08a08.jpg GRAPHIC 190983
6 GRAPHIC g770368g09p22.jpg GRAPHIC 149395
7 GRAPHIC g770368g10p21.jpg GRAPHIC 198026
8 GRAPHIC g770368g12p12.jpg GRAPHIC 51060
  Complete submission text file 0001193125-24-036598.txt   1643940
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-273984 | Film No.: 24640614
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)